Literature DB >> 1389944

Drug therapy of ulcerative colitis.

B Crotty1, D P Jewell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1389944      PMCID： PMC1381388          DOI： 10.1111/j.1365-2125.1992.tb04124.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  140 in total

1.  Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

Authors:  N A Buckell; S R Gould; D W Day; J E Lennard-Jones; A M Edwards
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

2.  Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats.

Authors:  K M Das; J R Chowdhury; B Zapp; J W Fara
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

3.  Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.

Authors:  S S Rao; S A Dundas; C D Holdsworth; P A Cann; K R Palmer; C L Corbett
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

4.  Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.

Authors:  J L Wallace; G Steel; B J Whittle; V Lagente; B Vargaftig
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

5.  4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl.

Authors:  O H Nielsen; I Ahnfelt-Rønne
Journal:  Pharmacol Toxicol       Date:  1988-04

6.  5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis.

Authors:  W L Biddle; N J Greenberger; J T Swan; M S McPhee; P B Miner
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

7.  Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial.

Authors:  A L Ginsberg; L S Beck; T M McIntosh; L E Nochomovitz
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

8.  4-Aminosalicylic acid retention enemas in treatment of distal colitis.

Authors:  J Gandolfo; M Farthing; G Powers; K Eagen; M Goldberg; P Berman; M Kaplan
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

9.  Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulfasalazine, in rats.

Authors:  H J Pieniaszek; T R Bates
Journal:  J Pharm Sci       Date:  1979-10       Impact factor: 3.534

10.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321
View more
  6 in total

1.  Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease.

Authors:  Heejung Kim; Hyesik Kong; Boim Choi; Youngwook Yang; Youngmi Kim; Mi Jung Lim; Len Neckers; Yunjin Jung
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

2.  Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.

Authors:  M J Elder; J Leonard; J K Dart
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

3.  Synthesis and Characterization of 5-Aminosalicylic Acid Based Poly(anhydride-esters) by Solution Polymerization.

Authors:  Youngmi Kim; Kathryn E Uhrich
Journal:  J Polym Sci A Polym Chem       Date:  2010-12-15       Impact factor: 2.702

4.  Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.

Authors:  Inho Kim; Hyesik Kong; Younghyun Lee; Sungchae Hong; Jungoh Han; Sunhwa Jung; Yunjin Jung; Young Mi Kim
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

5.  Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis.

Authors:  Yonghyun Lee; Seongkeun Jeong; Wooseong Kim; Hyunjeong Kim; Jeong-Hyun Yoon; Seong Hoon Jeong; Yunjin Jung
Journal:  Dig Dis Sci       Date:  2012-11-29       Impact factor: 3.199

6.  Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid.

Authors:  Diana Serra; Joana Paixão; Carla Nunes; Teresa C P Dinis; Leonor M Almeida
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.